InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV – Get Rating) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.94 and traded as high as $6.50. InVivo Therapeutics shares last traded at $5.92, with a volume of 70,934 shares.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on InVivo Therapeutics in a report on Saturday. They issued a “sell” rating for the company.
InVivo Therapeutics Stock Up 7.4 %
The firm has a 50 day moving average price of $5.70 and a 200 day moving average price of $5.94. The stock has a market cap of $8.23 million, a P/E ratio of -0.77 and a beta of 1.05.
Hedge Funds Weigh In On InVivo Therapeutics
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI.
- Get a free copy of the StockNews.com research report on InVivo Therapeutics (NVIV)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for InVivo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InVivo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.